Targeting secondary cardiovascular events

Low-dose Xarelto has been listed on the PBS in combination with aspirin, for the prevention of major cardiovascular events in high-risk patients While pharmacists have been familiar with Xarelto (rivaroxaban) in the wider cardiovascular space for over a decade, the drug is now available in a new low dose (2.5mg, twice daily) formulation, as a